secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0000950142-22-003473
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics receives Nasdaq deficiency notice for bid price below $1.00 per share
--------------------------------------------------------------------------------

- Received Nasdaq letter on Dec 22, 2022, citing non-compliance with Rule 5550(a)(2) due to closing bid below $1.00 for 30 consecutive business days.
- Has 180 calendar days, until June 20, 2023, to regain compliance by closing bid at or above $1.00 for 10 consecutive business days.
- Company is evaluating options to regain compliance; if unsuccessful, stock may be delisted from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222003473/0000950142-22-003473-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000095014222003473/eh220315769_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950142-22-003473

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer